Providers/Grant Support
This activity is supported by an educational grant from Merck Sharp & Dohme LLC.
Credits Available
- 1.0 ACCME, ANCC/CA-BRN, AAPA, ACPE, IPCE
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of pediatricians, family medicine physicians, neonatologists, nurse practitioners, physician associates, and pharmacists who provide care to infants and young children at risk for RSV.
Program Overview
This activity consists of five paired conversations with experts in nursing, pediatrics, and neonatology. During these conversations, the faculty explore the basics of respiratory syncytial virus (RSV) infection and illness, currently available immunoprophylaxis strategies, and tools to assist clinicians in preventing RSV among infants and young children. In particular, the activity provides in-depth discussion of RSV antibodies, detailing clinical evidence and recommendations to support their benefits and use.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Describe the burden of disease and risk factors related to RSV infection for infants and young children.
- Utilize clinical data to provide parents with evidence-based information on RSV immunoprophylaxis.
- Incorporate RSV preventive antibodies into preventive health recommendations for infants and young children in alignment with ACIP guidance.
Faculty
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Adjunct Clinical Assistant Professor
Stony Brook University School of Nursing
Stony Brook, New York
Lisa Saiman, MD, MPH
Professor of Pediatrics
Columbia University Irving Medical Center
Pediatric Infectious Diseases
New York, New York
Pablo J. Sánchez, MD
Professor of Pediatrics
Nationwide Children’s Hospital, The Ohio State University College of Medicine
Divisions of Neonatology and Pediatric Infectious Diseases
Center for Perinatal Research
The Abigail Wexner Research Institute at Nationwide Children's Hospital
Columbus, Ohio
Accreditation Statement
In support of improving patient care, Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education
Credit Designation
Physician Credit
The Annenberg Center designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate Credit
The Annenberg Center has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid until TBD.
PAs should only claim credit commensurate with the extent of their participation.
Pharmacist Credit
The Annenberg Center designates this knowledge-based activity for a maximum of 1 hour.
Credit will be provided to NABP CPE Monitor within 45 days after the activity completion.
Nurse Credit
The Annenberg Center designates this education for a maximum of 1 American Nurses Credentialing Center (ANCC) contact hour, including 0.5 pharmacology hour.
Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1 contact hour. To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
Disclosures of Conflicts of Interest
Lisa Saiman, MD, MPH
Data Monitoring Safety Board: Merck & Co., Inc.
Research Support: AstraZeneca, Merck & Co., Inc.
Pablo J. Sánchez, MD
Consultant: Merck Sharp & Dome
The following have no relevant financial relationships to disclose:
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
The faculty for this activity has disclosed that there will be discussion about the use of products for non-FDA approved indications.
Additional content planners
The following have no relevant financial relationships to disclose:
Kam Newman, MD (Peer Reviewer)
Jordan Covvey, PharmD, PhD, BCPS (Medical Writer)
Amber Lambert, DNP, FNP-C (Nurse Reviewer)
Annenberg Center for Health Sciences
All staff at the Annenberg Center have no relevant financial relationships to disclose.
All the relevant financial relationships listed for these individuals have been mitigated.
Instructions For Participation and Credit
This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the materials, reflecting on its implications in your practice, and completing the assessment component.
Disclosure of Unlabeled Use
The faculty for this activity has disclosed that there will be discussion about the use of products for non-FDA approved indications.
Disclaimer
The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center for Health Sciences at Eisenhower disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.
Contact Information
For CME questions please contact: [email protected]